Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
US-Listed Public Company Profile built from SEC and market records · June 2026

IQVIA HOLDINGS INC. (IQV)

$273.60 -2.06% NYSE: IQV · 15-min delayed
  • DURHAM, North Carolina
  • Public · NYSE: IQV
  • 93,000 employees
$34.7BMarket cap
$16.3BRevenue · FY2025
$1.4BNet income
93,000Employees
IQVNYSE
2013IPO

About IQVIA HOLDINGS INC.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$16.3B
Net income
$1.4B
Total assets
$29.9B
Market cap
$34.7B

Source: SEC EDGAR · updated Jun 7, 2026

NYSE: IQV
$273.60 -2.06%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$156.66 $279.36

52-week range

Market cap
$34.7B
Shares outstanding
126.9M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
May 9, 2013

Iqvia Holdings Inc. (IQV) Stock Price

  • Profitable — net income of $1.4B in FY2025.
  • Trading near its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review IQVIA HOLDINGS INC..

Write a review
Newsroom

News about IQVIA HOLDINGS INC.

News & sentiment via Polygon.io

FAQ

Iqvia Holdings Inc.: frequently asked questions

Is Iqvia Holdings Inc. an American company?

Yes — Iqvia Holdings Inc. is an American company. Iqvia Holdings Inc. is incorporated in Delaware, United States and headquartered in Durham, North Carolina. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Where is Iqvia Holdings Inc. incorporated?

Iqvia Holdings Inc. is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.

Who owns Iqvia Holdings Inc.?

Iqvia Holdings Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.

Is Iqvia Holdings Inc. traded on a US stock exchange?

Yes — Iqvia Holdings Inc. trades under the ticker IQV on the NYSE.

Where is Iqvia Holdings Inc. headquartered?

Iqvia Holdings Inc. is headquartered in Durham, North Carolina, United States.

Is Iqvia Holdings Inc. publicly traded?

Yes — Iqvia Holdings Inc. is a publicly traded company. Its stock trades under the ticker symbol IQV on the NYSE.

What does Iqvia Holdings Inc. do?

Iqvia Holdings Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →